Sinovac’s Limited Distribution in Africa May End Up Being a Blessing if Omicron Spreads

Source: Bridge Consulting

Distribution of Sinovac’s CoronaVac COVID-19 vaccine remains relatively limited in Africa, according to data from Bridge Consulting’s weekly vaccine tracker report. So, if the vaccine is not able to effectively counteract the Omicron variant, the overall impact will be limited.

Jabs made by Sinopharm account for the bulk of Chinese vaccine sales and donations in Africa and it is still not known how effectively their vaccine is able to protect against the new variant.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.